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862-4 Robotically-Assisted Ventricular Resynchronization 
Therapy Following Failed Coronary Sinus Cannulation 
JoseDh J. DeRose, Jr, Robert C. Ashton. Jr., Scott Belsley, Roxana Shaw. Daniel G. 
Swistel, Jonathan Sackner-Bernstein. Jonathan S. Steinberg, St. Luke’s_ Roosevelt 
Hospital Center, New York, NY, Columbia Universrty College of Physicians and 
Surgeons, New York, NY 
Background: Approximately 10% of patients undergoing biventricular pacemaker inser- 
tion have a failure of coronary sinus (CS) cannulation. We hypothesized that biventricular 
pacing could be performed in these patients using a robotically assisted, direct left ven- 
tricular (LV) epicardial approach. 
Methods: Seven patients with congestive heart failure (NYHA class 3.4 * 0.5) and a wid- 
ened QRS (175 * 21 msec) underwent robotic LV lead placement following failed coro- 
nary sinus cannulation. Mean patient age was 69 * 11 years, LV ejection fraction (EF) 
was 13 * 7% and left ventricular end diastolic volume was 6.3 * 0.5 cm. Two patients had 
prior cardiac surgery and 5 patients had a prior device implanted. 
Results: Thirteen epicardial leads were successfully placed on the posterolateral suriace 
of the LV in the 7 patients. lntraoperative lead threshold was 1.1 * 0.6 V at 0.5 ms. R- 
wave was 15.8 f 6.5 mV, and impedance was 1074 * 301 ohms at 0.5V. Complications 
mcluded one post-operatwe pneumonia and one episode of ventricular tachycardia in a 
patrent with an AICD. Improvements in exercise tolerance (5 of 7 patients), ejection frac- 
tion (19 f 10%) and QRS duration (152 i 16 msec) have been noted at 16.5 t 5.0 weeks 
follow-up. Lead thresholds have remained unchanged (1.8 * 1.1 Vat 0.5 ms, p=NS), and 
a srgnificant drop in impedance (310 + 54 ohms, p=O.O05) has been measured. 
Conclusions: Robotic LV lead placement is an effective technique which can be used for 
ventricular resynchronization therapy in patients with no other minimally invasive options 
for biventricular pacing. 
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873-2 Implantable Cardioverter Defibrillator Lead 
Complications and Laser Extraction in Children and 
Young Adults With Congenital Heart Disease 
Joshua M. Cooter, Elizabeth A. Stephenson, Charles I. Berul, Edward P. Walsh, 
Laurence M. Epstein, Brigham &Women’s Hospital, Boston, MA, Boston Children’s 
Hospital, Boston, MA 
Background: Implantable cardioverter-defibrillators (ICDs) are being implanted in chil- 
dren and young adults with congenital heart disease (CHD) for primary and secondary 
prevention of sudden death. ICD leads, over time, become adherent to venc~us endothe- 
lium and endocardium through the growth of scar tissue. This lead bindrng has unique 
implications in a growing patient. Lead removal, when necessary for lead infection or 
fracture, requires disruption of the adherent fibrous tiswe. Methods: We retrospectively 
reviewed our experience with ICD lead complications and extraction in children and 
young adults with CHD. Multiple implantation and extraction parameters were analyzed 
in this cohort, including demographics, cardiac anatomy, duration of Implantation. indica- 
tions for removal, and extraction procedure details. Results: From April 1999 through 
January 2002, 14 patients underwent 15 lead extraction procedures to remove 21 leads 
(17 ICD leads and 4 pacing or sensing leads). Seven patrents had surgically-corrected 
structural heart disease (5 transposition of the great arteries with atrial switch repair, and 
2 corrected tetralogy of Fallot). The mean patient age at extraction was 17.9 + 5.7 years 
(9 to 32 years), and the mean duration of lead implantation was 42.0 * 18.9 months (15 
to 75 months). Fourteen of 15 procedures were performed for lead fracture or failure. 
Binding of the proximal high voltage electrode, with coil stretching and fracture over time, 
is a newly-reported finding. A laser sheath was used for 20 of 21 lead extractions. Twenty 
of 21 leads (95%) were completely extracted. There were three instances of blood loss 
requiring transfusion. There were no major complications or deaths. Use of a laser 
sheath in the 5 patients with atnal switch repair of transposition of the great arteries drd 
not result in baffle injury.Conclusions: Young CHD patrents with an ICD are at risk for 
growth-related lead distortion and fracture. The use of a laser sheath is safe and effective 
for ICD lead extraction in CHD patients, despite the issues of coil adherence and altered 
cardiac anatomy. It may be advisable to implant single rather than dual coil ICD leads in 
patients with the potential for future growth. 
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873-3 Frequency and Timing of Defibrillator Events in Patients 
Without Documented Arrhythmias: Who Is at Highest 
Risk? 
Andrea M. Russq Sanjay Dixit. Ralph J. Verdino, Hemal Nayak. Joseph Poku, Jamre 
Springman, Laurent Lewkowiez, Francis E. Marchlinski, University of Pennsylvanra 
Health System, Philadelphia, PA 
Background: The frequency of appropriate implantable cardioverter defrbnllator (ICD) 
events in patients (pts) presenting with sustained ventricular arrhythmias (VAs) is well 
established. However, the frequency and timing of ICD events in other populations is not 
well described. Methods: We examined ICD events in 3 populations: Group 1 sustained 
VAs. Group 2 nonischemic dilated cardiomyopathy (DCM) and syncope, and Group 3 
asymptomatic nonsustained ventricular tachycardia, coronary disease and left ventncular 
dysfunction. Results: (^p<O.O5. compared to group 1) 
Conclusions: (1) The overall frequency of VAs is greatest in pts with clinically docu- 
mented VA prior to ICD implantation. (2) Compared to pts with sustained VAs. (a) pts 
with DCM and syncope were as likely to have VAs detected, despite shorter follow-up; 
(b) asymptomatic pts with coronary disease appeared less likely to have VAs detected, 
but this may be due to the much shorter median follow-up. (3) The time to the 1st sus- 
tained VA event was not significantly different in all 3 groups. These data support contin- 
ued ICD implantation for both primary and secondary prevention. 
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873-l Survival of Dialysis Patients After Cardiac Arrest in the 
United States: The Impact of Implantable Cardioverter 
Defibrillators 
Charles A. Herzoq, Jennie Z. Ma, Allan J. Collins, Nephrology Analytical Services, 
Minneapolrs. MN, Minneapolis Medical Research Foundation, Minneapolis, MN 
Sudden cardiac death is the single largest cause of mortality rn dtalysis pts. There are no 
published data on the impact of implantable cardioverter-defibrillators (ICD) on the sur- 
vival of dialysis pts with cardiac arrest. We searched the records (claims data) of 
1,285,177 pts in the 100% ESRD (end-stage renal disease) sample of the Medicare 
database and identified 15,531 dialysis pts hospitalized for cardiac arrest in 1996.2000. 
The survival of pts discharged alive receiving ICD withrn 30 days of cardiac arrest was 
compared to pts drscharged alive without ICD, using lrfe table method and a comorbidity- 
adjusted Cax model. 
Results ICD was used rn 167 pts, and 3,380 pts were discharged alive and received no 
ICD. Of the 3547 pts, 48% were male, 56% 65+ yrs old, 61% white, 53% diabetic ESRD, 
and 77% prior CHF. Predictors of death included older age, race (white), diabetes (DM), 
CHF. and no ICD. The Table shows suwival and predictors of death. Conclusion: The 
survival of dialysis pts with cardiac arrest is markedly improved by ICD. These data 
strongly suggest under-utilization of ICD in ESRD pts. 
Survival (%) Predictors of All-Cause Death 
ICD 
(n=167) 
No ICD 
(n=3,380) 
‘Yr 2Yr 3yr Varrable RR (95% Cl) 
P 
61.8 49.4 31. Age 1.6 (1.40,1.99) <.OOO 
6 75+ 7 1 
40.4 26.2 17. Male 1.1 (1.07.1.25) .0003 
9 6 
Race(Black) 0.8 (0.76.0.90) c.000 
2 1 
DM 1.2 (1.10,1.32) <.OOO 
0 1 
ICD 0.5 (0.43,0.66) c.000 
3 1 
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Median follow-up, days 
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Total # VA detections 
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Survival, % pts 
% pts wrth inappropriate ICD detections 
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